HealthEquity (HQY) Given Coverage Optimism Rating of 0.09

News coverage about HealthEquity (NASDAQ:HQY) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. HealthEquity earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.2981227003451 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

HealthEquity (HQY) traded up $1.30 during trading hours on Tuesday, hitting $51.31. 321,187 shares of the stock were exchanged, compared to its average volume of 530,656. The company has a market cap of $3,030.00, a P/E ratio of 79.64, a price-to-earnings-growth ratio of 2.20 and a beta of 1.77. HealthEquity has a one year low of $37.62 and a one year high of $55.31.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.13. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The company had revenue of $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. During the same period last year, the firm earned $0.16 EPS. The firm’s revenue for the quarter was up 28.7% compared to the same quarter last year. equities research analysts anticipate that HealthEquity will post 0.7 EPS for the current year.

HQY has been the subject of a number of research reports. BidaskClub downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. TheStreet raised shares of HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 price objective on shares of HealthEquity in a report on Tuesday, August 29th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $61.00 price objective on shares of HealthEquity in a report on Wednesday, September 6th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. HealthEquity presently has an average rating of “Buy” and a consensus price target of $57.50.

ILLEGAL ACTIVITY NOTICE: This report was published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.com-unik.info/2017/11/21/healthequity-hqy-given-coverage-optimism-rating-of-0-09.html.

In related news, VP Ashley Dreier sold 10,000 shares of HealthEquity stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $45.50, for a total transaction of $455,000.00. Following the completion of the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at approximately $712,166. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Jon Soldan sold 25,000 shares of the firm’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $40.68, for a total transaction of $1,017,000.00. Following the completion of the sale, the vice president now owns 30,652 shares of the company’s stock, valued at approximately $1,246,923.36. The disclosure for this sale can be found here. Insiders have sold a total of 1,578,270 shares of company stock valued at $82,355,799 over the last three months. 19.00% of the stock is currently owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

What are top analysts saying about HealthEquity Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthEquity Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit